STOCK TITAN

Precision Optics Corporation (POCI) Stock Price, News & Analysis

POCI NASDAQ
Published by Stock Titan Data refreshed

Price Move History

Daily moves over 5%
24 252 sessions, October 8, 2025 to October 8, 2026
Largest daily move
+17.5% close of November 11, 2025
1-year change
+7.2% closing prices, October 8, 2025 to October 8, 2026
1-month change
+6.4% closing prices, September 8, 2026 to October 8, 2026

Company Description

Precision Optics Corporation, Inc. (NASDAQ: POCI) is a vertically integrated optics company that designs, develops and manufactures advanced optical instruments for the healthcare and defense/aerospace industries. Founded in 1982, the company focuses on leveraging its proprietary micro-optics, 3D imaging and digital imaging technologies to support customers from new product concept through mass manufacture.

Within healthcare, Precision Optics works with next generation medical device companies that address the needs of the surgical community for more enhanced and smaller imaging systems used in minimally invasive surgery and in 3D endoscopy systems that support the proliferation of surgical robotic systems. The company has supplied top tier medical device companies with a variety of optical products for decades, including complex endocouplers and specialized endoscopes. According to additional disclosures, the company also manufactures medical products such as endoscopes and endocouplers for minimally invasive surgical and diagnostic procedures and designs and manufactures custom optical medical devices to meet specific customer requirements.

In the defense and aerospace markets, Precision Optics applies its micro-optics and imaging capabilities to applications that require high quality standards and careful optimization of size, weight and power. Recent company announcements describe work on sub-assemblies for advanced augmented reality (AR) systems for fighter pilot training and on a high-end, small-diameter borescope designed in multiple configurations to measure critical components inside jet engines in the field with greater-than-1080p HD resolution and performance in extreme environmental conditions. The company also manufactures and sells components and assemblies specially designed for industrial and military use.

Precision Optics emphasizes in-house capabilities that span design, prototyping, regulatory support and fabrication. It also utilizes the resources of its Ross Optical division, which provides high volume worldwide sourcing, inspecting and production resources. This combination allows the company to design and manufacture next-generation product solutions tailored to demanding customer requirements in both healthcare and defense/aerospace settings.

The company reports that it earns the majority of its revenue from the United States and that its business includes both engineering/development revenue and production revenue, reflecting its role in early-stage product development as well as ongoing manufacturing. Management communications highlight multi-year agreements with top tier aerospace and surgical robotics companies, as well as a growing production backlog that has led to facility expansion and additional production lines for specific customer programs.

Precision Optics has announced plans to move its corporate offices, including executive leadership, product development engineering, program management, human resources, business development and accounting, from Gardner, Massachusetts to Littleton, Massachusetts, while consolidating dedicated production capabilities at existing facilities in Gardner. The company has also referenced a facility in South Portland, Maine, which, together with the new Littleton site, is intended to provide access to a broader engineering talent pool to support its product development pipeline.

As part of its financial communications, Precision Optics discloses both GAAP results and a non-GAAP metric, Adjusted EBITDA, which excludes interest, taxes, depreciation, amortization and stock-based compensation. Management states that Adjusted EBITDA is used internally to compare operating performance over time and to evaluate business performance and trends.

Business model and revenue mix

According to company disclosures, Precision Optics generates revenue from engineering/development services and from production deliveries. Engineering revenue is tied to product development projects, such as AR sub-assemblies and jet engine borescopes, where the company provides design, prototyping and qualification services. Production revenue arises from manufacturing optical instruments, sub-assemblies and components, including single-use endoscope assemblies, complex endocouplers and specialized endoscopes, under ongoing customer programs and multi-year agreements.

Management commentary in recent financial results highlights the impact of multi-year agreements with a top tier aerospace company and a surgical robotics company, as well as increased production to meet growing demand from these customers. The company has also reported adding a second production line for single-use endoscope assemblies for a leading surgical company’s cystoscopy surgery system.

Industry positioning

Precision Optics operates at the intersection of surgical and medical instrument manufacturing and advanced optics for defense and aerospace. In healthcare, its focus on micro-optics, 3D imaging and digital imaging supports trends toward minimally invasive surgery and robotic-assisted procedures, where smaller, higher-performance imaging systems are required. In defense and aerospace, the company’s work on AR systems for pilot training and high-resolution borescopes for jet engines reflects demand for compact, high-performance optical systems that can function in challenging environments.

The company’s vertically integrated model, combining in-house design, prototyping, regulatory and fabrication with Ross Optical’s sourcing and production resources, is presented as a way to handle complex customer requirements from early concept through scaled manufacturing.

Key focus areas

  • Healthcare imaging systems: Micro-optics, 3D imaging and digital imaging for minimally invasive surgery and 3D endoscopy, including complex endocouplers, specialized endoscopes and single-use endoscope assemblies.
  • Surgical robotics support: Optical systems that support 3D endoscopy and imaging needs associated with the proliferation of surgical robotic systems.
  • Defense and aerospace optics: Optical sub-assemblies for augmented reality systems for fighter pilot training, and high-end borescopes for jet engine inspection in extreme conditions.
  • Industrial and military components: Components and assemblies designed for industrial and military use, drawing on the company’s micro-optics and imaging expertise.
  • Engineering and production services: End-to-end support from new product concept and design through prototyping, regulatory-related work and mass manufacture.

Risk and disclosure practices

In its public communications, Precision Optics includes forward-looking statements regarding projections for revenue, gross margins and Adjusted EBITDA, and notes that these projections are subject to risks and uncertainties, including demand for the company’s products, global supply chains, economic conditions and other factors identified in its SEC filings. The company also provides reconciliations of non-GAAP measures, such as Adjusted EBITDA, to the most directly comparable GAAP measures in its financial tables.

Frequently asked questions about Precision Optics Corporation (POCI)

Stock Performance

$4.60
-1.39%
0.07
Last updated: October 9, 2026 at 11:48
+7.2%
Performance 1 year
$50.5M

Precision Optics Corporation (POCI) closed at $4.67 on October 8, 2026. Over the past 12 months, the price has gained 7.2%.

See what a $1,000 investment in POCI would be worth today

POCI Metrics & Rankings

Price returns through October 8, 2026. Month-to-date and YTD include the first trading day. Ranking links may use different dates.

Financial Highlights

Precision Optics Corporation generated $31.5M in revenue in FY2026, retaining a 17.2% gross margin, operating income reached -$3.5M (-11.1% operating margin), and net income was -$3.6M, reflecting a -11.5% net profit margin. Diluted earnings per share stood at -$0.43. The company generated -$1.6M in operating cash flow. The current ratio was 2.28, measuring current assets divided by current liabilities.

$31.5M
Revenue (FY2026)
-$3.6M
Net Income (FY2026)
-$1.6M
Operating Cash Flow

Upcoming Events

AUG
18
August 18, 2027 Financial

Option vesting installment

First annual vesting of 16,666.67 shares from 50,000 inducement option granted 2026-08-18; subject to continued service and NASDAQ rules.
AUG
18
August 18, 2028 Financial

Option vesting installment

Second annual vesting of 16,666.67 shares from 50,000 inducement option granted 2026-08-18; contingent on continued employment.
AUG
18
August 18, 2029 Financial

Option vesting installment

Final annual vesting of 16,666.66 shares from 50,000 inducement option granted 2026-08-18; vests over three years subject to service.
AUG
18
August 18, 2036 Financial

Option expiration date

Inducement stock option 50,000-share granted 2026-08-18 has a 10-year term and expires on 2036-08-18; exercise price = 2026-08-18 close.

Precision Optics Corporation has 4 upcoming scheduled events. The next event, "Option vesting installment", is scheduled for August 18, 2027 (in 312 days). 4 of the upcoming events are financial in nature, such as earnings calls or quarterly results. Investors can track these dates to stay informed about potential catalysts that may affect the POCI stock price.

Short Interest History

Last 12 Months

Short interest in Precision Optics Corporation (POCI) currently stands at 7.0 thousand shares, down 35.9% from the previous reporting period, representing 0.1% of the float. Since October 2025, short interest has decreased by 69.7%.

Days to Cover History

Last 12 Months

Days to cover for Precision Optics Corporation (POCI) currently stands at 1.0 days. The ratio is the reported short interest divided by the average daily trading volume. Across the settlements charted above, it has ranged from 1.0 to 4.4 days.

POCI Company Profile & Sector Positioning

Precision Optics Corporation (POCI) operates in the Medical Instruments & Supplies industry within the broader Healthcare sector and is listed on the NASDAQ.

Investors comparing POCI often look at related companies in the same sector, including Retractable Technologies, Inc (RVP), Milestone Scientific, Inc. (MLSS), Nephros Inc. (NEPH), Harvard Bioscience Inc (HBIO), and NexGel, Inc (NXGL). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate POCI's relative position within its industry.

Frequently Asked Questions

What is the current stock price of Precision Optics Corporation (POCI)?

The current stock price of Precision Optics Corporation (POCI) is $4.60 as of October 9, 2026.

What is the market cap of Precision Optics Corporation (POCI)?

The market cap of Precision Optics Corporation (POCI) is approximately $50.5M. Learn more about what market capitalization means .

What is the revenue of Precision Optics Corporation (POCI) stock?

The FY2026 revenue of Precision Optics Corporation (POCI) is $31.5M, from its most recent completed fiscal year.

What is the net income of Precision Optics Corporation (POCI)?

The FY2026 net income of Precision Optics Corporation (POCI) is -$3.6M, from its most recent completed fiscal year.

What is the earnings per share (EPS) of Precision Optics Corporation (POCI)?

The diluted earnings per share (EPS) of Precision Optics Corporation (POCI) is -$0.43 for FY2026, its most recent completed fiscal year. Learn more about EPS .

What is the operating cash flow of Precision Optics Corporation (POCI)?

The operating cash flow of Precision Optics Corporation (POCI) is -$1.6M. Learn about cash flow.

What is the profit margin of Precision Optics Corporation (POCI)?

The net profit margin of Precision Optics Corporation (POCI) is -11.5%. Learn about profit margins.

What is the operating margin of Precision Optics Corporation (POCI)?

The operating profit margin of Precision Optics Corporation (POCI) is -11.1%. Learn about operating margins.

What is the gross margin of Precision Optics Corporation (POCI)?

The gross profit margin of Precision Optics Corporation (POCI) is 17.2%. Learn about gross margins.

What is the current ratio of Precision Optics Corporation (POCI)?

The current ratio of Precision Optics Corporation (POCI) is 2.28, measuring current assets divided by current liabilities. Learn about liquidity ratios.

What is the gross profit of Precision Optics Corporation (POCI)?

The gross profit of Precision Optics Corporation (POCI) is $5.4M for FY2026, its most recent completed fiscal year.

What is the operating income of Precision Optics Corporation (POCI)?

The operating income of Precision Optics Corporation (POCI) is -$3.5M. Learn about operating income.

What does Precision Optics Corporation (POCI) do?

Precision Optics Corporation designs, develops and manufactures advanced optical instruments for the healthcare and defense/aerospace industries. It focuses on proprietary micro-optics, 3D imaging and digital imaging technologies, providing services that span from new product concept through mass manufacture.

In which industries does Precision Optics primarily operate?

The company primarily serves the healthcare and defense/aerospace industries. In healthcare, it supports minimally invasive surgery and 3D endoscopy, including applications in surgical robotic systems. In defense and aerospace, it works on applications such as augmented reality systems for pilot training and high-end borescopes for jet engine inspection.

What types of medical products does Precision Optics manufacture?

According to company disclosures, Precision Optics manufactures medical products such as endoscopes and endocouplers used in minimally invasive surgical and diagnostic procedures. It also designs and manufactures custom optical medical devices, complex endocouplers, specialized endoscopes and single-use endoscope assemblies for specific customer systems.

How is Precision Optics involved in surgical robotics?

Within healthcare, Precision Optics enables next generation medical device companies to meet the demands of the surgical community for enhanced and smaller imaging systems. This includes 3D endoscopy systems that support the rapid proliferation of surgical robotic systems, where high-quality, compact imaging is essential.

What role does Precision Optics play in defense and aerospace applications?

The company leverages its micro-optics and imaging expertise to support leading edge defense and aerospace applications that require high quality standards and optimization of size, weight and power. Recent announcements describe development of sub-assemblies for advanced augmented reality systems for fighter pilot training and high-end borescopes for jet engine inspection.

What is meant by Precision Optics being a vertically integrated optics company?

Precision Optics describes itself as vertically integrated because it offers in-house design, prototype, regulatory and fabrication capabilities, and also uses its Ross Optical division for high volume worldwide sourcing, inspecting and production resources. This structure allows the company to support customers from early product concept through mass manufacture.

Where is Precision Optics Corporation based?

Company announcements reference operations in Massachusetts and Maine. Precision Optics has stated that it is moving its corporate offices from Gardner, Massachusetts to Littleton, Massachusetts, while maintaining and expanding production capabilities in Gardner and operating an additional facility in South Portland, Maine.

How does Precision Optics describe its revenue mix?

In its financial communications, the company distinguishes between engineering revenue and production revenue. Engineering revenue is associated with product development projects, while production revenue comes from manufacturing optical instruments, sub-assemblies and components under ongoing customer programs and multi-year agreements.

What is Adjusted EBITDA as used by Precision Optics?

Precision Optics reports Adjusted EBITDA as a non-GAAP financial measure that starts from net income (loss) and excludes interest, taxes, depreciation, amortization and stock-based compensation. Management states that this measure helps compare operating performance over time and evaluate financial and business trends.

Does Precision Optics serve customers outside the United States?

The company states that it enables next generation medical device companies around the world to meet the demands of the surgical community. It also notes that it earns the majority of its revenue from the United States, which implies that there is some revenue from outside the U.S.